Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$917M |
| 2 |
Salesforce
CRM
|
+$378M |
| 3 |
Boeing
BA
|
+$297M |
| 4 |
DexCom
DXCM
|
+$292M |
| 5 |
Amazon
AMZN
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DRE
Duke Realty Corp.
DRE
|
+$779M |
| 2 |
Chevron
CVX
|
+$569M |
| 3 |
Home Depot
HD
|
+$292M |
| 4 |
PepsiCo
PEP
|
+$259M |
| 5 |
Chubb
CB
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 52.94% |
| 2 | Technology | 8.23% |
| 3 | Healthcare | 7.53% |
| 4 | Financials | 7.5% |
| 5 | Industrials | 5.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4776
BlackRock Corporate High Yield Fund
HYT
$1.35B
| $443K | ﹤0.01% |
50,670
-39,768
| -44% | -$347K |
|
|
LENZ
4777
LENZ Therapeutics
LENZ
$161M
| $443K | ﹤0.01% |
19,049
-31,047
| -62% | -$720K |
|
|
IMAQR
4778
CALL
DELISTED
International Media Acquisition Corp. Rights
IMAQR
| $443K | ﹤0.01% |
43,384
| – | – |
|
4779
Runway Growth Finance
RWAY
$276M
| $442K | ﹤0.01% |
38,171
-10,861
| -22% | -$131K |
|
|
EPIX
4780
DELISTED
ESSA Pharma
EPIX
| $440K | ﹤0.01% |
174,475
-232,286
| -57% | -$667K |
|
|
QFTA
4781
DELISTED
Quantum FinTech Acquisition Corporation
QFTA
| $440K | ﹤0.01% |
43,750
-401,957
| -90% | -$3.99M |
|
4782
Rush Enterprises Class B
RUSHB
$8.34B
| $437K | ﹤0.01% |
11,660
+4,947
| +74% | +$175K |
|
4783
Alliance Entertainment
AENT
$280M
| $436K | ﹤0.01% |
42,827
| – | – |
|
4784
Standex International
SXI
$3.62B
| $436K | ﹤0.01% |
4,256
-24,235
| -85% | -$2.38M |
|
4785
Citius Pharmaceuticals
CTXR
$16.5M
| $435K | ﹤0.01% |
22,045
-9,346
| -30% | -$255K |
|
4786
Verastem
VSTM
$654M
| $435K | ﹤0.01% |
90,112
-178,412
| -66% | -$876K |
|
4787
ProFrac Holding
ACDC
$909M
| $434K | ﹤0.01% |
+17,241
| New | +$381K |
|
4788
Grupo Aval
AVAL
$6.23B
| $434K | ﹤0.01% |
+171,680
| New | +$397K |
|
4789
CALL
Lumen
LUMN
$6.23B
| $434K | ﹤0.01% |
+83,100
| New | +$511K |
|
4790
Rani Therapeutics
RANI
$97M
| $432K | ﹤0.01% |
73,144
-15,990
| -18% | -$117K |
|
|
USER
4791
CALL
DELISTED
UserTesting, Inc.
USER
| $432K | ﹤0.01% |
+57,500
| New | +$368K |
|
4792
Airgain
AIRG
$67.6M
| $431K | ﹤0.01% |
66,137
+18,575
| +39% | +$134K |
|
4793
Flexsteel Industries
FLXS
$333M
| $430K | ﹤0.01% |
27,954
-30,039
| -52% | -$451K |
|
4794
CALL
Maravai LifeSciences
MRVI
$1.14B
| $429K | ﹤0.01% |
30,000
-63,800
| -68% | -$1M |
|
4795
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.38B
| $427K | ﹤0.01% |
+13,247
| New | +$466K |
|
|
KE
4796
Kimball Electronics
KE
$564M
| $426K | ﹤0.01% |
18,878
-60,418
| -76% | -$1.29M |
|
4797
PUT
AMC Entertainment Holdings
AMC
$2.31B
| $425K | ﹤0.01% |
11,340
+9,690
| +587% | +$611K |
|
4798
Gulfport Energy Corp
GPOR
$3.12B
| $425K | ﹤0.01% |
5,777
-3,616
| -38% | -$299K |
|
4799
UGI
UGI
$8.15B
| $425K | ﹤0.01% |
11,478
-246,224
| -96% | -$8.9M |
|
|
DCH
4800
Dauch Corp
DCH
$1.5B
| $423K | ﹤0.01% |
54,135
-1,377,472
| -96% | -$12.3M |
|
Similar funds
Israel Englander's Q4 2022 Portfolio in Review
As of Q4 2022, Israel Englander held 7,859 positions worth $181B, up 6.9% from $169B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Israel Englander's Q4 2022 filing shows 848 new, 2,516 increased, 2,491 reduced and 1,332 closed positions. Its largest new stake was Keurig Dr Pepper: 4,680,704 shares worth $167M. The largest sale was Duke Realty Corp., an estimated $779M.
By sector, the portfolio is most concentrated in Miscellaneous at 53% of assets, down from 55% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q4 2022 buy was Keurig Dr Pepper: 4,680,704 shares worth $167M.
- Israel Englander added most to Invesco QQQ Trust in Q4 2022, an estimated $917M increase.
- Israel Englander's biggest Q4 2022 reduction was Chevron, cutting an estimated $569M.
- Israel Englander fully exited Duke Realty Corp. in Q4 2022, selling an estimated $779M.
- Israel Englander's ten largest holdings make up 20% of its $181B portfolio in Q4 2022.
- Israel Englander opened 848 new positions and closed 1,332 in Q4 2022.
- Israel Englander's portfolio value rose 6.9% quarter-over-quarter to $181B.
Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.